Growing community of inventors

Boston, MA, United States of America

Steven Thomas Dock

Average Co-Inventor Count = 5.71

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Steven Thomas DockVed P Srivastava (4 patents)Steven Thomas DockRobert Neil Hunter, Iii (4 patents)Steven Thomas DockAndrew A Young (3 patents)Steven Thomas DockWilliam Blackwell (3 patents)Steven Thomas DockMark A Paulik (3 patents)Steven Thomas DockYulin Wu (1 patent)Steven Thomas DockAndrew James Carpenter (1 patent)Steven Thomas DockYulin Wu (1 patent)Steven Thomas DockRobert Neil Hunter (1 patent)Steven Thomas DockIii Robert Neil Hunter (0 patent)Steven Thomas DockIii Robert Neil Hunter (0 patent)Steven Thomas DockSteven Thomas Dock (4 patents)Ved P SrivastavaVed P Srivastava (8 patents)Robert Neil Hunter, IiiRobert Neil Hunter, Iii (4 patents)Andrew A YoungAndrew A Young (68 patents)William BlackwellWilliam Blackwell (7 patents)Mark A PaulikMark A Paulik (4 patents)Yulin WuYulin Wu (3 patents)Andrew James CarpenterAndrew James Carpenter (3 patents)Yulin WuYulin Wu (2 patents)Robert Neil HunterRobert Neil Hunter (1 patent)Iii Robert Neil HunterIii Robert Neil Hunter (0 patent)Iii Robert Neil HunterIii Robert Neil Hunter (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Intarcia Therapeutics, Inc. (2 from 67 patents)

2. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)

3. I2o Therapeutics, Inc. (1 from 8 patents)


4 patents:

1. 11840559 - Glucagon-receptor selective polypeptides and methods of use thereof

2. 11214607 - Glucagon-receptor selective polypeptides and methods of use thereof

3. 10501517 - Glucagon-receptor selective polypeptides and methods of use thereof

4. 9441023 - Peptide YY analogs

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…